Tetanus

From injuries to infectious diseases, what are the health risks in the aftermath of PNG’s landslide?

Retrieved on: 
日曜日, 6月 2, 2024

More than 7,800 people have been affected by the landslide, including more than 3,300 children.

Key Points: 
  • More than 7,800 people have been affected by the landslide, including more than 3,300 children.
  • This could mean they’ve been displaced from their homes or are lacking access to basic necessities.
  • So what are the potential health risks following a landslide?

From injuries to illness

  • People may become trapped as the landslide carries buildings, structures and people in an unpredictable manner.
  • The Enga landslide happened in the middle of the night, which sadly meant most people could not escape in time.
  • Early efforts after a natural disaster almost always focus on minimising casualties and providing essential and immediate medical care.
  • Aceh also saw clusters of measles after the tsunami due to overcrowding among displaced populations, combined with patchy vaccination coverage.

Health system weaknesses

  • The risk of infectious diseases outbreaks in PNG stems from some underlying weaknesses in the health system, and poorer health outcomes.
  • For example, in PNG, it’s estimated that for children under five years old, 41 children die for every 1,000 live births.
  • In Australia, this number is ten times lower, at four deaths per 1,000 live births.

Mitigating the risks

  • We also know individuals affected by natural disasters can face mental health problems and gender-based violence.
  • Beyond providing medical care, local and international agencies are working to offer shelter, clean water and food, and mental health support to affected people.
  • For example, in Fiji after cyclone Winston in 2016, a similar surveillance system detected outbreaks of influenza, conjunctivitis and typhoid.

A rough road

“Walgreens En Tu Comunidad” Fosters Community in Puerto Rico with Health Fair Aimed to Increase Access and Education of Certain Health Services

Retrieved on: 
火曜日, 5月 28, 2024

As a trusted health and wellness destination in Puerto Rico, Walgreens is bringing the community together in San Juan by launching its first community health fair, “Walgreens en tu Comunidad,” to offer health-related education, screenings and vaccinations.

Key Points: 
  • As a trusted health and wellness destination in Puerto Rico, Walgreens is bringing the community together in San Juan by launching its first community health fair, “Walgreens en tu Comunidad,” to offer health-related education, screenings and vaccinations.
  • Programming will also include remarks by Puerto Rico senator Nitza Moran Trinidad, Tracey Brown, chief customer officer at Walgreens, among others.
  • In addition to this, the Centros Sor Isolina Ferré will provide education on their services offered for children with special needs.
  • Prenatal Care & Maternal Health: Vitamin Angels will provide expectant mothers with free prenatal vitamins and nutrition education information.

ILiAD Biotechnologies Reports Positive Topline Interim Results from Phase 2b School-Age Trial of BPZE1 Pertussis Vaccine

Retrieved on: 
火曜日, 5月 28, 2024

ILiAD Biotechnologies, LLC (ILiAD) reported today that BPZE1, the most advanced next generation pertussis vaccine, demonstrated positive topline interim results in the SUPER (Stand Up to Pertussis) school-age trial conducted in 366 participants in the United Kingdom, Australia and Costa Rica.

Key Points: 
  • ILiAD Biotechnologies, LLC (ILiAD) reported today that BPZE1, the most advanced next generation pertussis vaccine, demonstrated positive topline interim results in the SUPER (Stand Up to Pertussis) school-age trial conducted in 366 participants in the United Kingdom, Australia and Costa Rica.
  • The primary safety objective is to assess reactogenicity through 7 days following vaccination with BPZE1 alone, BPZE1 + Tdap, or Tdap alone.
  • Previous BPZE1 trials primarily evaluated BPZE1 in adults who received a first-generation whole cell pertussis (wP) vaccine as infants.
  • In this trial, BPZE1 demonstrated induction of mucosal immunity in children, which supports its potential to prevent the pervasive cycle of B. pertussis transmission.”

Rite Aid and Bartell Drugs Host Monthly Immunization Days This Summer

Retrieved on: 
水曜日, 5月 1, 2024

Rite Aid (OTC: RADCQ) and Bartell Drugs will offer a monthly Family Immunization Day event from 10 a.m. to 6 p.m. the first Wednesday of each month, beginning May 1 through August 7 at select locations.

Key Points: 
  • Rite Aid (OTC: RADCQ) and Bartell Drugs will offer a monthly Family Immunization Day event from 10 a.m. to 6 p.m. the first Wednesday of each month, beginning May 1 through August 7 at select locations.
  • Customers who are unable to attend an Immunization Day at a participating Immunization Day location can schedule an appointment for necessary vaccinations at their local Rite Aid through the online scheduling tool .
  • Bartell Drugs customers may use their online scheduler as well.
  • To help customers determine which routine immunizations are right for them, Rite Aid offers an Immunization Evaluation Questionnaire on its website.

World Market for Vaccines 2024: From Smallpox to Polio - The Impact on Global Health - ResearchAndMarkets.com

Retrieved on: 
金曜日, 3月 22, 2024

The World Market for Vaccines, 2024 offers the most up-to-date and comprehensive analysis of adult and pediatric preventative vaccines.

Key Points: 
  • The World Market for Vaccines, 2024 offers the most up-to-date and comprehensive analysis of adult and pediatric preventative vaccines.
  • Since the early 2000s, the publisher has consistently published new editions of The World Market for Vaccines every two years.
  • The report includes market forecasts, company market share data, and expert market estimates for different vaccine categories.
  • The World Market for Vaccines, 2024 also examines market trends for human vaccines used to prevent various diseases.

Viral Sensitizers Market Research Report 2023: Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors - Global Industry Trends and Forecasts, 2020-2022 and 2023-2035 - ResearchAndMarkets.com

Retrieved on: 
火曜日, 2月 6, 2024

The "Viral Sensitizers Market: Distribution by Application Area (Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors) and Key Geographical Regions (North America, Europe and Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Viral Sensitizers Market: Distribution by Application Area (Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors) and Key Geographical Regions (North America, Europe and Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.
  • The market research report highlights the efforts of several stakeholders engaged in this rapidly evolving segment of the viral manufacturing industry.
  • Key takeaways of the viral sensitizers market report are briefly discussed below.
  • We have extensively studied the historical market data within this industry, in order to develop a deeper understanding of the evolutionary market trends.

Phreesia Joins Call to Action to Improve Adult Vaccination Rates

Retrieved on: 
火曜日, 1月 23, 2024

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates.

Key Points: 
  • Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates.
  • More than three in four adults are missing routinely recommended vaccines and, due to preventive care put on hold during the COVID-19 pandemic, low vaccination rates have worsened.
  • The mission of the campaign is to encourage healthcare providers to take action to improve the implementation of adult vaccination recommendations to protect adults from preventable illness, disability and death.
  • Within the last few years, Phreesia has delivered over 20.7 million messages to adults to encourage conversations with care teams about recommended vaccines.

DocGo Expands Mobile Health Services with Santa Cruz County, Arizona Department of Health

Retrieved on: 
火曜日, 12月 19, 2023

(Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona.

Key Points: 
  • (Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona.
  • Beginning in late November, DocGo now operates a mobile clinic to enhance vaccine accessibility in a rural area with limited access to medical resources.
  • Santa Cruz County is designated as a medically underserved area by the Arizona Department of Health Services.
  • DocGo previously offered flu and COVID vaccines in mobile clinics with Santa Cruz County Health Department, as well as with the Maricopa County Health Department and the state of Arizona Department of Health.

Rite Aid Helps Customers Prioritize Immunity During Busy Holiday Season with Flu Shot Fridays

Retrieved on: 
水曜日, 11月 29, 2023

Rite Aid’s upcoming Flu Shot Fridays allows families to conveniently receive routine vaccinations ahead of the holiday season.

Key Points: 
  • Rite Aid’s upcoming Flu Shot Fridays allows families to conveniently receive routine vaccinations ahead of the holiday season.
  • Customers receiving their flu shot will also receive coupons for $5 off a $25 in-store purchase* and a free cold drink.
  • ** Flu Shot Fridays will be held every Friday from Dec. 1-29, at select locations.
  • Customers are encouraged to schedule an appointment for necessary vaccinations at their local Rite Aid through the online scheduling tool , or walk-in during regular store hours on Flu Shot Fridays.

Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023

Retrieved on: 
土曜日, 11月 4, 2023

BRISBANE, Calif., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the presentation of three posters – including an additional analysis of week 36 data from the Phase 2b ORIGIN study demonstrating resolution of hematuria in the majority of patients – on the Company’s product candidate atacicept in patients with immunoglobulin A nephropathy (IgAN) at the American Society of Nephrology (ASN) Kidney Week 2023, in Philadelphia, PA.

Key Points: 
  • Analysis of week 36 data from Phase 2b ORIGIN study shows atacicept 150 mg substantially reduces serum Gd-IgA1 and resolves hematuria in the majority of patients.
  • Additional poster presentations provide further safety analysis of Phase 2b and details of pivotal Phase 3 clinical trial design, which is currently enrolling.
  • At week 36 of the ORIGIN Phase 2b study of atacicept in patients with IgAN, hematuria resolved in 80% of patients (n=12/15) receiving atacicept 150 mg compared to 5% (n=1/19) in the placebo group.
  • Through the randomized, placebo-controlled period, infections were balanced between atacicept and placebo in both the Phase 2a JANUS and Phase 2b ORIGIN studies.